Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world…

Overview of attention for article published in Frontiers in oncology, April 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,344 followers.

RT @FrontOncology: New research: Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic… #…

01 May 2023

Reply Repost Favourite

New research: Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic… #oncology https://t.co/nNVnTG4MwG

01 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.